What question did this study set out to answer?

The research aims to explore the impact of pembrolizumab on treating locally advanced head and neck cancer through immunotherapy.

April 10, 2026

Immunotherapy advances in head and neck cancer care: implications for prescribers

Key Points

The research aims to explore the impact of pembrolizumab on treating locally advanced head and neck cancer through immunotherapy.
Discusses immunotherapy approaches for head and neck cancer
Highlights the role of pembrolizumab
Examines the need for coordinated care among prescribers
Pembrolizumab shows promise in improving treatment outcomes
Highlights the importance of a patient-centred management approach
Suggests that prescribers must adapt to new treatment protocols

Abstract

Aysha Mendes discusses how pembrolizumab is reshaping the treatment of locally advanced head and neck cancer by introducing immunotherapy into treatment and care, requiring prescribers to recognise and support co-ordinated, patient-centred management across settings

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Aysha Mendes (Thu,) studied this question.

www.synapsesocial.com/papers/69d8970c6c1944d70ce08496 — DOI: https://doi.org/10.12968/jprp.2026.0040

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Immunotherapy advances in head and neck cancer care: implications for prescribers

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion